AT
ARase Therapeutics is a science-focused oncology company developing novel therapeutics. The company targets ADP-ribose Hydrolases, which function in therapeutically proven cancer stress pathways. This focus aims to exploit specific vulnerabilities within cancer cells for therapeutic intervention.
Updated 4 months ago
Funding
$17.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- ARase Therapeutics is a science-focused oncology company developing novel therapeutics. The company targets ADP-ribose Hydrolases, which function in therapeutically proven cancer stress pathways. This focus aims to exploit specific vulnerabilities within cancer cells for therapeutic intervention.